1. Home
  2. CIK vs BHST Comparison

CIK vs BHST Comparison

Compare CIK & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Credit Suisse Asset Management Income Fund Inc.

CIK

Credit Suisse Asset Management Income Fund Inc.

HOLD

Current Price

$2.82

Market Cap

154.7M

Sector

Finance

ML Signal

HOLD

Logo BioHarvest Sciences Inc. Common Stock

BHST

BioHarvest Sciences Inc. Common Stock

HOLD

Current Price

$6.39

Market Cap

162.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIK
BHST
Founded
1987
2007
Country
United States
Canada
Employees
N/A
N/A
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
154.7M
162.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CIK
BHST
Price
$2.82
$6.39
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.00
AVG Volume (30 Days)
115.4K
107.0K
Earning Date
01-01-0001
11-13-2025
Dividend Yield
9.03%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$32,720,000.00
Revenue This Year
N/A
$116.40
Revenue Next Year
N/A
$55.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
45.88
52 Week Low
$2.50
$4.72
52 Week High
$3.19
$12.80

Technical Indicators

Market Signals
Indicator
CIK
BHST
Relative Strength Index (RSI) 46.16 38.86
Support Level $2.81 $6.25
Resistance Level $2.85 $7.20
Average True Range (ATR) 0.03 0.72
MACD 0.01 0.09
Stochastic Oscillator 68.18 24.49

Price Performance

Historical Comparison
CIK
BHST

About CIK Credit Suisse Asset Management Income Fund Inc.

Credit Suisse Asset Mgmt Income Fund Inc is a closed-end management investment company. The investment objective of the fund is to provide current income consistent with the preservation of capital. Credit Suisse serves as an investment adviser for the fund. Asset Management offers a wide range of investment products and functions across asset classes and investment styles. The division manages various regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations and individuals.

About BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

Share on Social Networks: